Preventive cognitive therapy (PCT) has the potential to significantly reduce the burden of recurrent depression, one of the leading causes of disability worldwide. By showing that strengthening positive emotions and the ability to experience pleasure can lower relapse risk, this research offers a new pathway for improving long term mental health outcomes. The findings help clinicians tailor treatments that not only reduce symptoms but also build resilience, ultimately supporting individuals in maintaining recovery, reducing healthcare costs, and improving overall quality of life.
The study included 69 unmedicated individuals with remitted MDD at high risk for recurrence from the NEWPRIDE randomized controlled trial. The findings showed a 3-month PCT intervention directly improved consummatory pleasure, the inverse of anhedonia, and increased use of cognitive reappraisal, which together contributed to reductions in dysfunctional attitudes associated with relapse vulnerability. Change in anhedonia (odds ratio [OR], 0.79; 95% CI, 0.68–0.92; P =.003] and dysfunctional attitudes (OR, 0.93; 95% CI, 0.86–0.99; P =.041) predicted relapse status at 18-month follow-up in PCT-recipients.
The findings suggest that strengthening positive affect may be a key mechanism for reducing relapse in recurrent depression, but these mechanisms require further validation in broader populations. Future work may explore how strategies that enhance pleasure and positive emotions can be integrated into preventive treatments, potentially improving resilience and reducing vulnerability to recurrence.
